| Net Cash Provided by (Used in) Operating Activities |
$45,030 |
USD |
-295% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$1,265,316 |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,083,860 |
USD |
-36% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
14,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
531,172 |
shares |
0.9% |
Q4 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$136,426 |
USD |
|
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,561,434 |
USD |
-36% |
Q4 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$587,347 |
USD |
17% |
Q2 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$6,749 |
USD |
-47% |
Q2 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$829,951 |
USD |
|
Q4 2025 |
Q3 2026 |
| Deferred Income Tax Expense (Benefit) |
$52,916 |
USD |
-291% |
Q2 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |